Cross-institution positioning
Aug 14, 2026Strong institutional reduction. 3 reducing, 1 exited across 4 comparable institutions.
Source: Schedule 13 researchNEW YORK TIMES CO
Latest stored close $66.32 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 3 reducing, 1 exited across 4 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +11.2% YoY; Net income +12.6% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 53% through its reported 52-week range; +21.0% over one year.
Source: Stored historical price seriesFiled Aug 14, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Bardeen William | FTax/price withholding or payment | Class A Common Stock | 485 | $63.54 | Direct | Aug 13, 2026 |
| Aug 10, 2026 | Perpich David S. | FTax/price withholding or payment | Class A Common Stock | 131 | $63.54 | Direct | Aug 12, 2026 |
| Jul 23, 2026 | VAN DYCK REBECCA | AGrant, award, or other acquisition | Class A Common Stock | 176 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Subramanian Anuradha B. | AGrant, award, or other acquisition | Class A Common Stock | 36 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | ROGERS JOHN W JR | AGrant, award, or other acquisition | Class A Common Stock | 106 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | MCANDREWS BRIAN P | AGrant, award, or other acquisition | Class A Common Stock | 176 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Glaser Rachel C | AGrant, award, or other acquisition | Class A Common Stock | 110 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Brooke Beth A. | AGrant, award, or other acquisition | Class A Common Stock | 68 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Bronstein Manuel | AGrant, award, or other acquisition | Class A Common Stock | 62 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Bhutani Amanpal Singh | AGrant, award, or other acquisition | Class A Common Stock | 98 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | GOLDEN MARGOT | AGrant, award, or other acquisition | Class A Common Stock | 31 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | GOLDEN ARTHUR S. | AGrant, award, or other acquisition | Class A Common Stock | 70 | $0.00 | Direct | Jul 27, 2026 |
| Jun 3, 2026 | Welch Jacqueline M | SOpen-market or private sale | Class A Common Stock | 4.0K | $74.14 | Direct | Jun 5, 2026 |
| May 12, 2026 | KOPIT LEVIEN MEREDITH A. | SOpen-market or private sale | Class A Common Stock | 9.8K | $78.00 | Direct | May 14, 2026 |
| May 12, 2026 | Bardeen William | SOpen-market or private sale | Class A Common Stock | 4.1K | $77.85 | Direct | May 14, 2026 |
| May 11, 2026 | Perpich David S. | GGift | Class A Common Stock | 500 | $0.00 | Direct | May 12, 2026 |
| May 11, 2026 | Perpich David S. | SOpen-market or private sale | Class A Common Stock | 9.0K | $77.06 | Direct | May 12, 2026 |
| Apr 22, 2026 | GOLDEN MARGOT | AGrant, award, or other acquisition | Class A Common Stock | 2.3K | $0.00 | Direct | Apr 24, 2026 |
| Apr 22, 2026 | GOLDEN ARTHUR S. | AGrant, award, or other acquisition | Class A Common Stock | 2.3K | $0.00 | Direct | Apr 24, 2026 |
| Apr 22, 2026 | Glaser Rachel C | AGrant, award, or other acquisition | Class A Common Stock | 2.3K | $0.00 | Direct | Apr 24, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 9, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Aug 5, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 23, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Feb 27, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| Feb 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 21, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Nov 5, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $762.5M | +11.2% |
| Ended Mar 31, 2026 | $712.2M | +12.0% |
| Ended Sep 30, 2025 | $700.8M | +9.5% |
| Ended Jun 30, 2025 | $685.9M | +9.7% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $2.8B | +9.2% |
| Ended Dec 31, 2024 | $2.6B | +6.6% |
| Ended Dec 31, 2023 | $2.4B | +5.1% |
| Ended Dec 31, 2022 | $2.3B | +11.3% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Jun 30, 2026 observed Aug 14, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 8.1M -2.2M | 5.00% -1.30 pts | $69.98 | $64.79 | $66.32 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 6.5M | $66.32 | |||
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 observed Jul 31, 2026 filed · 31d Schedule 13G amendment | Reported reduction | 7.7M -478.5K | 12.00% +6.89 pts | $69.98 | $74.89 | $66.32 |
Compare NYT with other securities showing similar institutional activity or recent accumulation across several tracked institutions.